Tower Research Capital (TRC)’s NexImmune, Inc. Common Stock NEXI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-2,121
| Closed | -$5.85K | – | 6135 |
|
2024
Q2 | $5.85K | Buy |
2,121
+541
| +34% | +$1.49K | ﹤0.01% | 4644 |
|
2024
Q1 | $8.86K | Sell |
1,580
-221
| -12% | -$1.24K | ﹤0.01% | 3944 |
|
2023
Q4 | $4K | Buy |
1,801
+1,545
| +604% | +$3.43K | ﹤0.01% | 5010 |
|
2023
Q3 | $1.34K | Hold |
256
| – | – | ﹤0.01% | 5358 |
|
2023
Q2 | $1.8K | Sell |
256
-5
| -2% | -$35 | ﹤0.01% | 5292 |
|
2023
Q1 | $2K | Hold |
261
| – | – | ﹤0.01% | 5432 |
|
2022
Q4 | $2K | Sell |
261
-296
| -53% | -$2.27K | ﹤0.01% | 5463 |
|
2022
Q3 | $8K | Buy |
557
+383
| +220% | +$5.5K | ﹤0.01% | 4835 |
|
2022
Q2 | $7K | Sell |
174
-71
| -29% | -$2.86K | ﹤0.01% | 4847 |
|
2022
Q1 | $26K | Buy |
245
+132
| +117% | +$14K | ﹤0.01% | 3302 |
|
2021
Q4 | $13K | Buy |
113
+92
| +438% | +$10.6K | ﹤0.01% | 4221 |
|
2021
Q3 | $8K | Sell |
21
-34
| -62% | -$13K | ﹤0.01% | 4583 |
|
2021
Q2 | $22K | Buy |
55
+45
| +450% | +$18K | ﹤0.01% | 3820 |
|
2021
Q1 | $5K | Buy |
+10
| New | +$5K | ﹤0.01% | 4717 |
|